CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases

Taebum Lee, Boram Lee, Yoon-La Choi, Joungho Han, Myung-Ju Ahn, Sang-Won Um

JPTM. 2016;50(3):197-203. Published online 2016 April 18 DOI: https://doi.org/10.4132/jptm.2016.03.09

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases

Taebum Lee, Boram Lee, Yoon-La Choi, Joungho Han, Myung-Ju Ahn, Sang-Won Um

Journal of Pathology and Translational Medicine. 2016;50(3):197-203

Link1

Link2 Link3

A long-term survivor of non-small-cell lung cancer harboring concomitant EGFR mutation and ALK translocation

Fumio Imamura, Takako Inoue, Madoka Kimura, Kazumi Nishino, Toru Kumagai

Respiratory Medicine Case Reports. 2016;19:137-139

Link1 Link2

P3.01-063 Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer

R. Chen, X. Zhang, Y. Wu, H. Chen, Q. Zhou, J. Su, H. Tu, Z. Xie, W. Zhong, J.-. Yang

Journal of Thoracic Oncology. 2017;12(11):S2225-S2226

Link1 Link2

Clinical features and therapeutic options in non‐small cell lung cancer patients with concomitant mutations of EGFR , ALK , ROS1 , KRAS or BRAF

Xibin Zhuang, Chao Zhao, Jiayu Li, Chunxia Su, Xiaoxia Chen, Shengxiang Ren, Xuefei Li, Caicun Zhou

Cancer Medicine. 2019;8(6):2858-2866

Link1 Link2 Link3 Link4

Routine EGFR and KRAS Mutation analysis using COLD-PCR in non-small cell lung cancer

A. Pennycuick, T. Simpson, D. Crawley, R. Lal, G. Santis, P. Cane, K. Tobal, J. Spicer

International Journal of Clinical Practice. 2012;66(8):748-752

Link1 Link2

Reply to Costs of ALK , ROS1 , EGFR , and KRAS testing in non-small cell lung cancer: About different strategies in France

Giancarlo Troncone

Cancer Cytopathology. 2017;125(11):877-877

Link1 Link2

39IN BEYOND EGFR, KRAS, ALK; WHAT ELSE?

T. Mitsudomi

Lung Cancer. 2011;71:S23

Link1 Link2

KRAS mutation, KRAS–LCS6 polymorphism, and non-small cell lung cancer

H.H. Nelson, B.C. Christensen, S.L. Plaza, J.K. Wiencke, C.J. Marsit, K.T. Kelsey

Lung Cancer. 2010;69(1):51-53

Link1 Link2

P136 KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer

J.-Y. Wang, S.-R. Lin

European Journal of Cancer Supplements. 2009;7(4):37

Link1 Link2

Costs of ALK , ROS1 , EGFR , and KRAS testing in non-small cell lung cancer: About different strategies in France

Laetitia Lambros, Briac Guibourg, Arnaud Uguen

Cancer Cytopathology. 2017;125(11):876-876

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. J Pathol Transl Med has participated in CrossRef Text and Data Mining service since January 16, 2015.